How COVID-19 could benefit tuberculosis and HIV services in South Africa.
Journal
The Lancet. Respiratory MedicinePublisher
ElsevierPubMed ID
32758439Type
ArticleLanguage
enEISSN
2213-2619ae974a485f413a2113503eed53cd6c53
10.1016/S2213-2600(20)30311-8
Scopus Count
Collections
Related articles
- From HIV to COVID-19: Focusing on and Engaging Adolescents and Young Adults During the Pandemic.
- Authors: DeLong SM, Denison JA, Yang C, Agwu A, Alexander KA, Kaufman MR, Arrington-Sanders R
- Issue date: 2020 Nov
- COVID-19 in Africa: community and digital technologies for tuberculosis management.
- Authors: Koura KG, Harries AD, Fujiwara PI, Dlodlo RA, Sansan EK, Kampoer B, Affolabi D, Combary A, Mbassa V, Gando H, Bangoura A, Assao M, Gning B, Dogo MF, Fiogbé A, Bridgen G
- Issue date: 2020 Aug 1
- Do facemasks protect against COVID-19?
- Authors: Isaacs D, Britton P, Howard-Jones A, Kesson A, Khatami A, Marais B, Nayda C, Outhred A
- Issue date: 2020 Jun
- COVID-19, Pandemic, and Social Distancing.
- Authors: Malay DS
- Issue date: 2020 May - Jun
- Use of facemasks during the COVID-19 pandemic.
- Authors: Schünemann HJ, Akl EA, Chou R, Chu DK, Loeb M, Lotfi T, Mustafa RA, Neumann I, Saxinger L, Sultan S, Mertz D
- Issue date: 2020 Oct